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Introduction 
On a rainy October afternoon in 1968, as my 
plane landed at Heathrow Airport from Budapest, I 
did not know that I would never return to the coun-
try of my birth and early youth. I arrived with a 
small suitcase and five pounds in my pocket. I was a 
fortunate and happy recipient of a Wellcome Re-
search Fellowship at £1,200 per annum, which had 
been awarded two years earlier. The Hungarian 
authorities, however, for reasons known only to 
themselves, did not give me an exit permit. My visit 
was on a knife edge until the last minute, for on the 
day when I was going to the British Consulate to 
apply for a visa, the Hungarian State Radio an-
nounced that the armies of the Warsaw Pact (in-
cluding Hungary’s) were giving “brotherly help” to 
the people of Czechoslovakia. Translating this Or-
wellian newspeak, it meant invading a friendly, 
neighbouring country. 
Arrival in London 
My first impression was compensation for all 
the preceding stress: my future boss, Professor 
Stanley Holt, met me at the airport and brought 
one of his assistants, who happened to be also a 
Hungarian and who left after the Revolution of 
1956. Holt (Fig 1), or “Holtie” to his friends, was a 
 
 
Fig 1 Professor Stanley Holt 
Reflections 
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cell biologist of international reputation. His De-
partment of Histochemistry of the Courtauld Insti-
tute of Biochemistry within the Middlesex Hospital 
Medical School, London, W1, which despite its 
small size, was a beehive of activity with young 
scientists from all over the world. He originally ex-
celled in histochemistry and later applied electron 
microscopy to the demonstration of enzymes – a 
methodology I learned from him. This expertise 
stood me in good stead one year later when I start-
ed to work on my PhD. He had lexicographic 
knowledge of a wide range of subjects (including an 
in-depth personal expertise of Scottish single malt 
whiskies), and was an excellent teacher and a most 
entertaining raconteur. 
In the late summer of 1969, as my Fellowship 
was coming to an end, I realised that, whatever 
happens, I was not returning to Hungary. The rea-
son for this decision was complex, but at its core 
was the discovery of personal freedom with the 
liberating feeling that I was in charge of my own 
destiny. Having experienced a new way of life, I felt 
that I could not conform to the rules and regula-
tions of life under Communism. 
“Defection”, my trial and prison sen-
tence in Hungary 
When I told Holtie of my decision, his re-
sponse was rapid and efficient as he went to see 
the Director of the Institute and the Secretary of 
the Medical School. The next couple of months 
remain memorable for the kindness and help of 
people who allayed my way of getting permission 
to stay in the United Kingdom, to find accommoda-
tion and, most importantly, a job. 
In the meantime I had to write an official let-
ter of resignation to my workplace, the Institute of 
Morbid Anatomy and Histopathology, Medical Uni-
versity in Szeged, Hungary. It was not an easy task. 
The response was immediate and brutal. The Rec-
tor of the University ordered a disciplinary action 
on the basis that I refused to return to Hungary. 
Since I failed to appear personally to present my 
case, I was summarily dismissed from employment. 
But this was not the end. I was also indicted with a 
criminal charge of refusing to return to Hungary. 
The trial took place, in my absence, on 9 February 
1970 in the District Court of Szeged. I was sen-
tenced to 16 months imprisonment as principal 
punishment and complete confiscation of all my 
belongings as secondary punishment. The latter I 
viewed with a sense of bitter irony, for it was for 
the third time in less than three decades that we 
lost all our material possessions: first, the Fascists 
took away everything in 1944, then the Com-
munists closed down the family’s enterprise in 
1949 and finally I lost everything in 1970, for my 
flat in Szeged had been sealed and sold with its 
contents. 
For many weeks after my “defection”, I had a 
recurring nightmare. I was getting on the plane at 
Budapest Airport and, as I was fastening my seat-
belt, a stewardess called my name and frog-
marched me off the plane. I was terrified; I would 
never fly to London. The nightmare always ended 
the same way - I awoke in a pool of sweat, but 
happily realising that I was in London after all. 
 
Fig 2 Copy of my photograph in the file of the Hungarian State 
Security, taken circa 1966 
Many years later in 2015, I learned that the 
Hungarian State Security (AVO) had a file on me 
(Fig 2). At my request its Archives sent a copy which 
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is now in my possession. It consists of 39 pages, 
with all the details of my trial and some other in-
formation that had been kept for decades. “Big 
Brother” had a long memory. 
The Middlesex Hospital Medical 
School, London 
My first appointment was a Research Assistant 
in the Bland-Sutton Institute of Pathology of the 
Middlesex Hospital at an annual salary of £2,160. 
Not knowing at the time, I was the first to be em-
ployed from the so-called “biscuit money.” In the 
1960s, Garfield Weston, multi-millioner owner of 
Fortnum and Mason (The Queen’s grocery shop) 
and many other outlets, donated a large sum of 
money to promote research into neurological dis-
eases at the Middlesex Hospital. This donation was, 
by the way, the seed from which the Reta Lila Wes-
ton Institute of Neurological Studies at University 
College London later blossomed. Professor George 
Dick, director of the Bland-Sutton, and Dr. Helen 
(“Wendy”) Grant, a consultant neuropathologist 
(Fig 3), were looking for a research worker who 
would examine ultrastructural abnormalities in 
progressive multifocal leukoencephalopathy (PML). 
This was an appointment clearly tailored for me, 
nevertheless I was formally interviewed. 
I started to investigate post-mortem brains 
with PML, but soon realised that the information 
we could get would not add a great deal to the 
existing knowledge. After an extensive literature 
search and discussions with Professor Dick and Dr 
Grant, I suggested that my project be in the field of 
experimental brain tumours. Two British biochem-
ists, Peter Magee and John Barnes, had discovered 
the carcinogenic actions of nitroso compounds in 
1956. Subsequent extensive investigations revealed 
that two nitrosoureas, methyl- and ethyl-
nitrosourea, have preferential carcinogenic actions 
in the nervous system. Ethyl-nitrosourea (ENU) 
when injected in a single dose to pregnant rats 
after the 15th day of gestation induces tumours at a 
rate of nearly 100% in the nervous systems of off-
spring. This is of paramount importance in carcino-
genesis; because the precise time of interaction 
between the carcinogen and the cells is known, it 
became possible to study carcinogenesis and the 
evolution of tumours from their inception. 
 
Fig 3 Dr. Helen (Wendy) Grant in 1987 
PhD on brain tumours 
It was at this time that I met a young German 
neuropathologist who expressed his ideas with 
enthusiasm and some force. We started to collabo-
rate and became friends: his name is Paul Kleihues 
and he came to work with Magee, a professor at 
the Courtauld Institute of Biochemistry. I started 
my project on the development of ENU-induced 
tumours of the nervous system in BD-IX rats in 
1970. The tumour yield of the offspring approached 
100% and I sequentially followed their growth from 
the earliest abnormal cell proliferations to fully 
developed malignant tumours. Pleomorphic glio-
mas, resembling human glioblastoma multiforme, 
have originated from undifferentiated cells of the 
subependymal plate. My first collaborator who 
joined me was also funded from the “biscuit mon-
ey”: Geoffrey Pilkington, 21 years old at the time at 
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the time of our collaborations, recently retired at 
the end of 2019 as Professor of Cellular and Molec-
ular Neuro-oncology. I submitted my PhD thesis to 
the University of London with the title, The Fine 
Structure and Enzyme Cytochemistry of Tumours 
Induced by N-Ethyl-N-Nitrosourea and was awarded 
in 1973. It might have been the last word in the 
field, but leafing through it now, its two volumes 
are fossils of a bygone era. 
While working on the PhD, I was also doing 
the occasional neurological post-mortems and 
looking at brain biopsies. At the advice of senior 
colleagues, I decided to prepare and sit for the 
MRCPath examination. To learn the “trade,” I visit-
ed many neuropathological departments in Eng-
land and abroad. On the basis of my PhD and pre-
vious experience in Hungary, I was exempted from 
the Primary and got successfully through the Final 
Examination in the winter of 1975. This I celebrated 
by treating myself to a round-the-world air ticket. 
In the summer of 1976, I was appointed Senior 
Lecturer in Neuropathology at the Middlesex Hos-
pital Medical School and Honorary Consultant to 
the Hospital. I already had my small research team 
working on experimental brain tumours and my 
first PhD student, who later became a Professor of 
Neurology in Athens, Greece. 
The changing ethos of medicine 
The Middlesex Hospital exists no more. First it 
fused with University College Hospital London 
(UCHL) to become “Unisex” for a couple of years 
while the new UCHL was built. It was later demol-
ished to give space to modern blocks of flats. Only 
its beautiful chapel – an oasis of peace and a place 
for reflection – has survived as a protected build-
ing. While I worked there from 1968 to 1980, it was 
a most pleasant and stimulating environment; the 
competence of its consultant staff was matched by 
the excellence of its academic life. Medicine by that 
time might not have been a vocation, but it was still 
a profession and not the business to which it has 
been degraded today. It was run by doctors for 
patients and not by managers for profit and quotas. 
When the UK went through turbulent economic 
and financial difficulties, we were encouraged to 
raise funds for research; yet the basic principle that 
it was the university which should provide funds for 
salaries and infrastructure still prevailed. This 
changing world was reflected even in the everyday 
attitude of employers. Young doctors of today 
would not believe that, for many years, it was a 
daily tradition at the Middlesex to lay out tea with 
cakes and sandwiches in the Senior Common Room 
– free. This is a far cry from now, when staff are 
expected to pay for parking at their work place. 
The Institute of Psychiatry/Maudsley 
In 1979, the Chair of Neuropathology at the 
Institute of Psychiatry (IoP) was advertised and I 
applied. To my surprise (and perhaps to every-
body’s), I was appointed in October of that year; 
exactly ten years after I had decided to remain in 
England. In the immediate euphoria and surprise, I 
did not realise that I arrived at the wrong place, at 
the wrong time. The Chair at the IoP was, at the 
time, one of the two established chairs of neuropa-
thology in the UK, created to acknowledge the 
work of Professor Alfred Meyer who escaped from 
Nazi Germany and built up the neuropathology 
laboratory at the Maudsley Hospital, London (Fig 4). 
 
Fig 4 Professor Alfred Meyer 
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I was the fourth incumbent of the Chair and 
did not realise that I was going to face an uphill 
struggle. In the late 1970s the UK was literally 
bankrupt and, after the “winter of discontent” 
when the country was paralysed by strikes, Marga-
ret Thatcher had won the election for the Con-
servative Party in May 1979. The new government 
embarked on an austerity policy that did not spare 
universities. The vacant jobs of two Senior Lectur-
ers and one Lecturer, advertised with the Chair, 
were “frozen” – the dreaded term I heard for the 
first, but unfortunately not the last time. The De-
partment was decimated; there was one full-time 
and one part-time Consultant, one Senior Registrar 
and a group of three neurophysiologists. However, 
there was no shortage of advice, with the best 
coming from Lucien Rubinstein in his letter of con-
gratulation. I will quote the penultimate sentences, 
for it is wise advice even for future generations: 
“The main thing is to plan carefully and deliberate-
ly, and recognize where action is possible and 
where it is futile. If you insist, however, long 
enough, often enough, and nicely enough, you will, 
we are sure, get your own way.” And this I tried to 
follow during the next 22 years: with more or less 
success. 
I made a plan for the first five years and de-
cided that I would resign if I did not succeed. First, 
with a major grant from the MRC and with Geoff 
Pilkington’s help, who came with me from the Mid-
dlesex Hospital, we redesigned and upgraded the 
Electron Microscope Unit. This was followed by 
modernising the histopathology laboratory and 
creating laboratories for immunohistochemistry, 
molecular biology, genetics and tissue culture. With 
the late Professor David Marsden, we successfully 
applied to the MRC for a grant to establish an Alz-
heimer’s and Parkinson’s Diseases Brain Bank. After 
he was appointed to the Chair of Neurology at the 
Institute of Neurology and Neurosurgery in London, 
we had a friendly “divorce.” The Parkinsonian com-
ponent moved with him, whilst the larger share 
stayed at the IoP to become a major resource of 
research. This Brain Bank is still flourishing under 
the directorship of Professor Safa Al-Sarraj, Head of 
Clinical Neuropathology. 
In 1985, with the spreading of HIV, the MRC 
funded an AIDS Brain Bank which became one of 
the national centres of AIDS research. By this time, 
the Department of Neuropathology expanded to 
occupy two floors in the IoP and had a foothold in 
the new Clinical Neuroscience building of King’s 
College Hospital. Research during the 1980s and 
1990s thrived, chiefly for two reasons. First, the 
Department was fortunate to attract talented 
young researchers, including trainees in neuropa-
thology, other clinicians (including psychiatrists), 
and a large group of non-medical neuroscientists. 
There were several independent, but collaborating 
research groups in neurodegeneration, HIV/AIDS, 
prion diseases, brain tumours, neuro-immunology, 
schizophrenia and autism. Second, although there 
was never enough money to cover everything we 
wanted to do, the Department was successful in 
getting long- and short-term grants. By this time 
the Department had some 50 members, including 
four Consultants and three secretaries. 
When the IoP merged with King’s College Lon-
don as part of the major re-structuring of medical 
schools and postgraduate institutes in London, I 
became the Clinical Director (Lead Clinician) of neu-
ropathology services covering a catchment area of 
3.5 million people. I also held Honorary Consultant 
contracts with the Maudsley, King’s College, Guy’s 
and St Thomas’ Hospitals. 
In 1992, I received the degree of DSc of the 
University of London, and in 2001 I was elected 
Fellow of the Academy of Medical Sciences. 
My main research interest was in neuro-
degeneration, particularly in familial and rarer de-
mentias and prion diseases. This included success-
ful collaboration with psychiatrists and neurologists 
of the IoP/Maudsley and elsewhere, both in Eng-
land and abroad. I was also invited to participate in 
three editions of the WHO classification of brain 
tumours (1993, 1997 and 2000), the clinico-
pathological definition of Pick’s disease, the Euro-
pean Network of Brain Tissue Bank (European Un-
ion), HIV infection of the nervous system diseases 
and Creutzfeldt-Jakob disease (International Socie-
ty of Neuropathology), and the definition and diag-
nostic criteria of corticobasal degeneration, supra-
nuclear palsy and multiple system atrophy (Nation-
al Institutes of Health of the USA). It is in multiple 
system atrophy in which we have made a signifi-
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cant contribution to the diagnosis and definition of 
disease. 
The Discovery of glial cytoplasmic in-
clusions, also (unfortunately NOT) 
known as Papp-Lantos inclusions 
In 1987, Mátyás Papp, Professor of Neurology 
and Neuropathology at the Semmelweis Medical 
University of Budapest (who in the early 1980s 
spent one year in my Department), sent me several 
cases of striatonigral degeneration, olivoponto-
cerebellar atrophy and Shy-Drager’s syndrome. He 
observed, by using the Gallyas’ technique, tangle-
like inclusions which occurred predominantly in 
oligodendrocytes. In London, we further character-
ised these inclusions by electron microscopy and 
immunocytochemistry (a state-of-the-art technique 
available at the time) and established that they 
were present in all three clinical syndromes. Later, 
it was found that these inclusions also contain ɑ-
synuclein. The fundamental importance of glial 
cytoplasmic inclusions are twofold. First, they are 
the hallmark cellular lesions – not in any way less 
important than Lewy bodies – by which these elu-
sive disorders can be confidently diagnosed. Sec-
ond, their presence in all three clinical syndromes 
demonstrated that they are a single nosological 
entity: multiple system atrophy. 
Editing Greenfield’s Neuropathology 
When Professor David Graham asked me in 
1992 whether I would co-edit the Sixth Edition of 
Greenfield’s Neuropathology, I had no hesitation to 
accept. Whilst editing textbooks never appealed to 
me, two titles were tempting: “Greenfield’s” and 
“Russell and Rubinstein”. Earlier, I was approached 
by the publisher of the latter, but the transatlantic 
negotiations came to a halt and I felt better not to 
be involved. 
The first edition of Greenfield’s was published 
in 1958 and the Fifth Edition of 1992 was not an 
unqualified success. We decided to have a different 
concept, content and design from the previous 
editions. With the support of Georgina Bentliff, this 
was the beginning of our harmonious collaboration 
of some ten years with the publishers: first Edward 
Arnold, then Hodder and Stoughton and finally 
Hodder Headline. The Sixth Edition, published in 
1997, was well received, collected a couple of priz-
es and had to be reprinted. The Seventh edition 
appeared on the market in 2002 and must have 
been regarded as a success, for the publisher gave 
a special, leather-bound copy to the two editors. 
The British Neuropathological Society 
British neuropathologists have two excellent 
forums dedicated to neuropathology: The British 
Neuropathological Society (BNS) and the bimonthly 
scientific journal, Neuropathology and Applied Neu-
robiology. In the past, the BNS had two annual 
meetings: in the winter in London with rotating 
venues and in the summer in the country at clinical 
neuroscience centres. The meetings were open to 
everybody who paid the registration fee. They were 
attended by neuropathologists and neuroscientists 
from other countries – mainly from Continental 
Europe. At their best, the meetings lasted two days 
and were frequently preceded by a symposium 
with invited speakers on selected, topical subjects. 
These were occasions as informative and stimulat-
ing scientifically as they were enjoyable socially. I 
joined the BNS in 1972, becoming its Vice-President 
in 1993-1995 and President in 1995-1997. 
The BNS first published Neuropathology and 
Applied Neuropathology in 1975 under the editor-
ship of Professor John Cavanagh, an outstanding 
neuroscientist with razor-sharp critical sense. He 
edited the journal until 1988 when, under Profes-
sor Roy Weller’s editorship, the journal continued 
to flourish as it does to the present day. 
The Problems of British Neuro-
pathology 
As Head of a large department of neuropa-
thology, I was aware of three chronic problems of 
our specialty. First, the complex and sometimes 
difficult relationship with histopathology, as re-
flected by the chronic “independence” fight with 
the Royal College of Pathologists for recognition as 
a separate specialty. This was less of a problem for 
departments which were part of a large clinical 
neuroscience centre, but more difficult for those 
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which were de facto part of a histopathology de-
partment. The Royal College of Pathologists even-
tually recognised neuropathology as a subspecialty, 
organised a Sub-Committee of Neuropathology of 
which I was Chairman (1987-1990), and allowed the 
Final Examination to be taken in neuropathology, 
overseen by a Panel of Examiners which I also 
chaired (1985-1990). 
Second, irrespective of location, the cost of 
neuropathology services was always a concern – 
increasingly so with the advent of managers and 
during the endless reorganisations. The argument 
that the post-mortem examination of brains and 
the diagnosis of biopsies from the nervous system 
may exceed the average cost was not always readi-
ly accepted. 
The third problem was recruitment. Unfortu-
nately, neuropathology is a small specialty and 
during my time the number of Consultants did not 
exceed 50 in the UK. Choosing neuropathology as a 
career in medicine had the potential difficulty of 
finding a consultant appointment after the comple-
tion of training – let alone getting one at a desired 
location. This clearly was a limiting factor, although 
both the MRC and the Wellcome Trust were most 
helpful by funding training positions in neuropa-
thology. 
Despite the rumours: there is life after 
retirement 
The publication of the Seventh Edition of 
Greenfield’s in 2002, coupled with other reasons, 
seemed to be the ideal time for my retirement. I 
also remembered my fore-teacher at school who 
advised to leave the party when one enjoys it most. 
Whilst I admire my colleagues who do not seem 
ever want to retire, I knew that I was not going to 
select this avenue, despite a couple of tempting 
offers for part-time work. I did love neuropathology 
and do not think, if I were starting again, I would 
choose another specialty within medicine. Overall I 
enjoyed my work, both at the Middlesex Hospital 
and at the IoP, but, apart from working pro bono 
for medical charities, retirement was a closure of 
my professional life. 
However, even after retirement, I followed 
the careers of those who worked with me. It is with 
some satisfaction to record that all my PhD stu-
dents (with the exception of one who has a leading 
position in the British pharmaceutical industry) 
became professors in their fields in this country, 
the USA, Ireland, Hungary and Greece. One is now 
Executive Dean of the IoP, which is still one of the 
leading centres of its type and now appropriately 
renamed the Institute of Psychiatry, Psychology 
and Neuroscience. Some of my young colleagues 
and trainees also had stellar careers: two at the 
Institute of Ophthalmology and one as the Director 
of the Wellcome Sanger Institute, having been 
knighted a few years ago. 
Immediately after retirement, I enrolled in a 
two-year Theology Course on Judaism, French and 
Hebrew classes and short cookery courses and 
demonstrations. However, these were only diver-
sions, for I had a project to pursue. 
Bergen-Belsen 
In the summer of 1944, as a child of five, I was 
deported with my parents first to Austria and then 
to Bergen-Belsen concentration camp in Germany. 
 
Fig 5 With my mother in 1946 
I was prisoner 8431, my mother 8517 and my 
father 8432. My father died there of starvation; my 
mother and I survived (Fig 5). Before the British 
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Army reached the camp, we were put on a train 
with destination Theresienstadt, another concen-
tration camp outside Prague. On the way our train 
was bombed by the Allies for they thought that it 
was carrying German troops, but finally we were 
liberated by the 30th Division of the 9th US Army on 
13 April 1945 outside a small village in eastern 
Germany. After travelling across war-torn Europe, 
we arrived home to an empty family house at the 
end of August 1945. My mother never talked about 
this experience – not until I was a teenager when I 
started to ask questions. 
Life under the Communists 
After the war, Hungary was a democratic 
country with a multi-party political system, free 
elections and an increasing living standard. Howev-
er, at the end of 1949 our normal life had abruptly 
changed. Insidiously increasing its power with the 
assistance of the Red Army, which by then had 
changed from a liberating to an occupying force, 
the Communist Party came to power to inaugurate 
years’ of terror. The Revolution of 1956 brought a 
few days’ of hope and freedom, only to be 
squashed by the Red Army and with the introduc-
tion of reinvigorated oppression. 
In 1958, after some difficulties and at the pro-
testation of my mother, my social classification was 
upgraded from “class alien” (which meant social 
death) to “other” (a dubious category with which 
one could just get by). I was admitted to the Medi-
cal University of Szeged (now named after Albert 
Szent-Györgyi, the Nobel Prize-winning scientist 
who worked there). Despite oppression until 1960 
– for example we knew there was at least one 
“student” who regularly reported on us to the po-
lice – I greatly enjoyed my university years. The 
main reason was the quality of teaching. There was 
an extensive and demanding curriculum, including 
a good balance between theory and practice in the 
form of lectures and practical classes. Despite the 
“Iron Curtain,” medical and scientific journals were 
available from all over the world, and from the late 
1950s senior staff could apply for fellowships in 
western countries. And this is how some years later 
I received a Wellcome Research Fellowship in 1966, 
as a Lecturer in the Institute of Morbid Anatomy 
and Histopathology. 
Revisiting Belsen 
I realised that as an adult, I knew very little of 
what had happened to us. After all, 21 members of 
my family perished in the Holocaust. 
 
Fig 6 With George Gross in San Diego in 2003 
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The aim of the project I embarked on was to 
fill this gap. However, I encountered a formidable 
obstacle at the very beginning in that most of the 
family documents had been lost during the war. 
Those which survived had been left, and presuma-
bly destroyed, in my flat in Szeged. To rekindle 
memories, during 2003 and 2004 I traced the foot-
steps my family made 60 years earlier in 1944 and 
1945. It was an exciting and rewarding time – a sort 
of research I had not done before: diving into the 
archives of four different countries and meeting 
other survivors and witnesses. Two witnesses, 
amongst the many, were unforgettable: the late 
George Gross, the American tank commander who 
liberated our train and whom I visited in San Diego, 
California (Fig 6) and the late Professor John 
Hankinson, Professor of Neurosurgery in Newcas-
tle, who as a last-year medical student volunteered 
to help in Belsen after liberation. For his work, the 
British Army presented him with a beautiful silver 
pocket watch which he passed on to me when I 
visited him in Newcastle. This is one of my most 
cherished possessions (Fig7). 
 
Fig 7 The silver pocket watch from Bergen-Belsen on the top of 
my bureau 
Reinventing myself as a self-employed 
author 
I had not planned to write a book about my 
childhood. However, with a large amount of mate-
rial from my travels, I started to make notes as a 
sort of aide memoire. The experience at the begin-
ning was quite unsettling, for there was an element 
of emotional involvement, completely different 
from the impersonal, objective and sparse style of 
medical/scientific writing – something I had prac-
tised for four decades. However, in the end, I had a 
manuscript and one of my friends, an editor, found 
a small publisher. Parallel Lines – a Journey from 
Childhood to Belsen was first published in 2006 by 
Arcadia Books London (Fig 8a). It was well received 
both in this country and abroad; it was translated 
into Hungarian (Sínek és Sorsok, Scolar 2009), Ital-
ian (Tracce di Memoria, Giunti 2015) and German 
(Von Ungarn nach Bergen-Belsen und zurück, 
Wallstein 2017). After attending medical/scientific 
meetings, symposia and workshops, it was a great 
change and exciting to be invited to literary festi-
vals and book launches in this country, the USA, 
Germany, Hungary, Australia and New Zealand. 
After Parallel Lines I wrote a novel, Closed 
Horizon, also published by Arcadia Books in 2012 
(Fig 8b). It is a dystopic novel which takes place in 
the surveillance state of the near future and it is a 
clash between the individual and the darker power 
of the state. 
“The play’s the thing” (Shakespeare) 
I never had any intention of writing plays and 
it was only the love of theatre which lead me to a 
short course, organised by the Writing Academy of 
the publisher Faber and Faber, on writing plays in 
2012. The course was good fun with two excellent 
tutors: one being a well-known playwright and the 
other the artistic director of a Central London thea-
tre. Thus, my playwriting “career” is entirely acci-
dental, but I enjoyed the idea of trying to bring 
characters to life by creating inner tensions and 
external conflicts. The research, which was essen-
tial for the historical background and characters of 
the plays, was very similar to the excitement of 
discoveries of medical research. Yet the world of 
theatres, actors, directors and agents is far re-
moved from the medical/scientific environment. It 
was not any less revelatory and exhilarating, yet far 
more uncertain and changeable – as if someone 
attempted to enter a mirage. Nothing exemplifies 
this more than the author relationships with pub-
lishers. Whilst medical publishers came to ask, or 
even begged, authors to write for them, one has to 
find a publisher in the in the literary world where 
there are over 160,000 titles a year. 
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Fig 8 Covers of my books 
The first three play were collected into a vol-
ume, Stolen Lives to form a trilogy (Regent Books 
London 2018; Fig 8c). All three take place in Hunga-
ry against historical turning points: The Visitor dur-
ing the Second World War; Distorting Mirrors in the 
1956 Revolution and Stolen Years at the fall of 
Communism in 1989. In all three, the source of 
drama is the same: human tragedy, in the form of 
an irredeemable conflict between vulnerable indi-
viduals and brutal authoritarian dictatorships re-
lentlessly motivated by an obnoxious ideology, be it 
Fascism or Communism. 
I have completed two more plays. Light and 
Shadow is the extraordinary love affair which shook 
puritanical Victorian London between the French 
painter James (Jacques) Tissot and Kathleen New-
ton, a Catholic Irish divorcée with an illegitimate 
child. My last play, Bread from Air: the Strange Case 
of Dr Haber has perhaps the most complex of char-
acters: Dr Fritz Haber the Nobel Laureate in Chem-
istry (1918), who by producing ammonia from hy-
drogen and nitrogen, the basic substance of ferti-
lisers, is credited with saving the lives of two out of 
the seven billion people alive today. Yet, it was also 
he who produced (on a scientific basis) poisonous 
gases, one of which was first introduced in 1915 
against French troops at Ypres. His private life was 
as contradictory and colourful as his professional 
career. He lived long enough to be refused entry by 
the Nazis into the Institute he founded which bore 
his name. Fortunately, he did not survive to witness 
the death of some of his relatives in Auschwitz, 
who were murdered by the same poisonous gas his 
team had experimented with in the 1920s. These 
two plays were published in a volume, Love and 
Obsession (Regent Books, 2019; Fig 8d). 
 
Fig 9 At the reading of one of my plays in 2015 
All these plays had professional rehearsed 
readings with actors – mostly in the theatre and 
one in the Tate Gallery – but none has had a full 
production yet (Fig 9). Now, with the pandemic 
creating grave consequences for theatres, it is even 
less likely that this will occur in the near future. 
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Nevertheless, I am working on my sixth play which, 
through its extraordinary heroine, brings together 
my country of birth and my adopted country. 
Epilogue or Final Curtain 
After 21 years of absence, I arrived at Buda-
pest Airport on a sunny September day in 1989. 
The city was more beautiful than I ever remem-
bered and was floating on a wave of expectation 
and hope. The still “socialist” government had just 
opened the border to Austria and this was the “be-
ginning of the end” of Communism, for the Berlin 
Wall came down two months later in November. 
For me this journey was of great importance, for it 
built a bridge between the two worlds in which I 
have lived: Hungary of my childhood and youth and 
England of my adult life. In the sunshine of eupho-
ria and wellbeing, I felt that a new Golden Age was 
dawning over Hungary, Europe and the World. 
Looking back now, I could not have been more 
wrong. Yet we should hope that common sense 
and decency will still prevail over madness and 
outrage; liberal democracy over dictatorships and 
populism (Fig 10). 
 
 
Fig 10 Peter Lantos today 
